128 related articles for article (PubMed ID: 16281077)
41. [Response rate of AML-XH-99 protocol in the treatment of 82 childhood acute myeloid leukemia].
Li J; Gu LJ; Xue HL; Tang JY; Chen J; Zhao HJ; Chen J; Pan C; Wang YP; Ye H
Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):351-4. PubMed ID: 15308014
[TBL] [Abstract][Full Text] [Related]
42. Pilot remission induction therapy with idarubicin, plus an intensified dose of ara-C and priming with granulocyte colony-stimulating factor for acute myeloid leukemia.
Baek JH; Sohn SK; Kim DH; Kim JG; Yang DH; Kim YK; Lee JJ; Kim HJ
Acta Haematol; 2007; 117(2):109-14. PubMed ID: 17135724
[TBL] [Abstract][Full Text] [Related]
43. Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia.
He XY; Pohlman B; Lichtin A; Rybicki L; Kalaycio M
Leukemia; 2003 Jun; 17(6):1078-84. PubMed ID: 12764371
[TBL] [Abstract][Full Text] [Related]
44. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
[TBL] [Abstract][Full Text] [Related]
45. [Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia].
Dłuzniewska A; Balwierz W; Balcerska A; Chybicka A; Kamieńska E; Karolczyk G; Karpińska-Derda I; Krawczuk-Rybak M; Kowalczyk JR; Lewandowska D; Maciejka-Kapuścińska L; Kołtano S; Malinowska I; Matysiak M; Mikołajczyk M; Mizia-Malarz A; Muszyńska-Rosłan K; Niedźwiedzki M; Pohorecka J; Sikorska-Fic B; Sobol G; Sońta-Jakimczyk D; Tomaszewska R; Urasiński T; Wachowiak J; Wieczorek M; Wójcik B; Wysocki M
Przegl Lek; 2010; 67(6):366-70. PubMed ID: 21344763
[TBL] [Abstract][Full Text] [Related]
46. Outcome of modified St Jude total therapy 13A for childhood acute lymphoblastic leukemia in the southeast region of Turkey.
Koc A; Aycicek A; Ozdemir ZC; Soker M; Varma M
J Pediatr Hematol Oncol; 2013 Jan; 35(1):36-41. PubMed ID: 23138117
[TBL] [Abstract][Full Text] [Related]
47. Treating childhood acute myeloid leukaemia with the AML-BFM-83 protocol: experience in a developing country.
Chan LL; Abdel-Latif ME; Ariffin WA; Ariffin H; Lin HP
Br J Haematol; 2004 Sep; 126(6):799-805. PubMed ID: 15352983
[TBL] [Abstract][Full Text] [Related]
48. Curing childhood acute myeloid leukemia (AML) at the half-way point: promises to keep and miles to go before we sleep.
Woods WG
Pediatr Blood Cancer; 2006 May; 46(5):565-9. PubMed ID: 16261562
[TBL] [Abstract][Full Text] [Related]
49. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.
Wells RJ; Adams MT; Alonzo TA; Arceci RJ; Buckley J; Buxton AB; Dusenbery K; Gamis A; Masterson M; Vik T; Warkentin P; Whitlock JA;
J Clin Oncol; 2003 Aug; 21(15):2940-7. PubMed ID: 12885813
[TBL] [Abstract][Full Text] [Related]
50. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
[TBL] [Abstract][Full Text] [Related]
51. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
52. Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases.
Pui CH; Relling MV; Rivera GK; Hancock ML; Raimondi SC; Heslop HE; Santana VM; Ribeiro RC; Sandlund JT; Mahmoud HH
Leukemia; 1995 Dec; 9(12):1990-6. PubMed ID: 8609707
[TBL] [Abstract][Full Text] [Related]
53. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.
Lange BJ; Kobrinsky N; Barnard DR; Arthur DC; Buckley JD; Howells WB; Gold S; Sanders J; Neudorf S; Smith FO; Woods WG
Blood; 1998 Jan; 91(2):608-15. PubMed ID: 9427716
[TBL] [Abstract][Full Text] [Related]
54. Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience.
Rubnitz JE; Lensing S; Razzouk BI; Pounds S; Pui CH; Ribeiro RC
Pediatr Blood Cancer; 2007 Jan; 48(1):10-5. PubMed ID: 16642489
[TBL] [Abstract][Full Text] [Related]
55. Acute myeloid leukaemia in childhood: the costs and benefits of intensive treatment.
Phillips M; Richards S; Chessells J
Br J Haematol; 1991 Apr; 77(4):473-7. PubMed ID: 1902743
[TBL] [Abstract][Full Text] [Related]
56. Second malignancy after treatment of childhood acute myeloid leukemia.
Leung W; Ribeiro RC; Hudson M; Tong X; Srivastava DK; Rubnitz JE; Sandlund JT; Razzouk BI; Evans WE; Pui CH
Leukemia; 2001 Jan; 15(1):41-5. PubMed ID: 11243397
[TBL] [Abstract][Full Text] [Related]
57. Current treatment and outcome for childhood acute leukemia in Tanzania.
Kersten E; Scanlan P; Dubois SG; Matthay KK
Pediatr Blood Cancer; 2013 Dec; 60(12):2047-53. PubMed ID: 24039163
[TBL] [Abstract][Full Text] [Related]
58. Clinical trials in AML of the elderly: should we change our methodology?
Estey E
Leukemia; 2004 Nov; 18(11):1772-4. PubMed ID: 15385922
[No Abstract] [Full Text] [Related]
59. The outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997-2008: A report from the Australian Paediatric Cancer Registry.
Foresto SA; Youlden DR; Baade PD; Hallahan AR; Aitken JF; Moore AS
Pediatr Blood Cancer; 2015 Sep; 62(9):1664-6. PubMed ID: 25855531
[TBL] [Abstract][Full Text] [Related]
60. Clonal remission in childhood acute myeloid leukemia is an infrequent event.
Smith FO; Raskind WH; Waldron P; Steinmann LJ; Matsushita M; Singer JW; Lampkin BC; Woods WG; Lange BJ; Hammond GD
Leukemia; 1993 Jul; 7(7):929-32. PubMed ID: 8100603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]